Autophagy inhibition sensitizes liver kinase b1 (LKB1)-deficient kras-driven lung tumors to MEK inhibitor trametinib.

Bhatt, VD; Lan, TJ; Wang, WP; Khayati, K; Cararo-Lopes, E; Wang, JM; Kong, J; Raju, A; Luo, XF; Hu, WW; Su, XY; White, E; Guo, JY

CANCER RESEARCH, 2021; 81 (13):